Gilead Sciences
Pharmaceutical & Health Products · Lobbying Client
Gilead Sciences's Federal Lobbying Record
At $17.0M in disclosed federal lobbying, Gilead Sciences ranks as a major spender — well above the typical filer. Outlays in this range generally reflect a sustained presence in Washington, with at least one full-time government affairs lead and a stable of outside lobbyists engaged on the organization's priority issues.
Across the 5-year window from 2020 to 2024, Gilead Sciences's annual disclosed lobbying spend has declined modestly — from $3.6M in 2020 to $3.4M in 2024, a change of -7%. Step-changes of this size often coincide with major bills moving through Congress, regulatory rulemakings affecting the organization's industry, or a leadership change in the relevant committee.
Gilead Sciences's disclosed lobbying covers 5 general issue areas — a moderate footprint. Filers in this range tend to engage on a coherent cluster of related topics rather than spreading effort across the federal agenda.
4 of 11 lobbyists reported by Gilead Sciences (36%) disclose prior federal government service. That share is common at established government affairs operations that explicitly hire from agency and committee staff.
Among the named bench, lobbyists with disclosed prior federal service include Paul H. Thompson (Former Senior Counsel, Senate Finance Committee); Joel N. Kaplan (Former Senior Advisor, White House); Lawrence J. Guillemette (Former Deputy Administrator, EPA). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.
Within the Pharmaceutical & Health Products sector, Gilead Sciences ranks #11 of 34 tracked organizations by disclosed lobbying spend. The sector leader is Pharmaceutical Research & Manufacturers of America at $135.8M; the sector average is $16.7M. Gilead Sciences's $17.0M sits 2% above the sector average.
Gilead Sciences's LobbySpend Influence Score of 59/100 (grade C) is the most common grade in the index — it covers organizations with established but moderate federal advocacy programs. The score combines disclosed total spend (40%), issue breadth (30%), and revolving-door connections (30%). A C-grade is typical of mid-size corporations and trade associations with steady quarterly filings on a focused issue set.
Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.
Track Gilead Sciences's lobbying filings
Subscribe for LobbySpend updates by email. No spam, unsubscribe anytime.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2024 Oct-Dec | Mehlman Consulting | HCRPHAGOV+2 | 2 | $849K |
| 2024 Jul-Sep | Capitol Counsel | HCRMEDTAX | 3 | $726K |
| 2024 Apr-Jun | Prime Policy Group | TAXMEDHCR | 4 | $798K |
| 2024 Jan-Mar | Subject Matter | GOVPHA | 2 | $874K |
| 2023 Oct-Dec | Akin Gump Strauss Hauer & Feld | TAXPHAMED+2 | 3 | $808K |
| 2023 Jul-Sep | Squire Patton Boggs | GOVPHA | 1 | $837K |
| 2023 Apr-Jun | Peck Madigan Jones | GOVTAXPHA | 1 | $931K |
| 2023 Jan-Mar | Mehlman Consulting | HCRGOVMED+1 | 1 | $681K |
Gilead Sciences Lobbying FAQ
Gilead Sciences has spent $17.0M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.
Gilead Sciences lobbies on 5 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.
Gilead Sciences has an Influence Score of 59/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).
Gilead Sciences employs 11 registered lobbyists, of whom 4 have revolving door connections, meaning they previously held government positions before becoming lobbyists.
Gilead Sciences has contacted 7 government entities as part of their lobbying activities, including Dept of Defense, Centers for Medicare & Medicaid Services, Dept of the Interior.
Explore Other Lobbying Organizations
$387.8M lobbying spend · Trade Association · Influence Score B
$348.2M lobbying spend · Real Estate · Influence Score B
$135.8M lobbying spend · Pharmaceutical & Health Products · Influence Score B
$128.0M lobbying spend · Healthcare · Influence Score B
Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.